Centre To Convert 2,000 Agri Societies Into Jan Aushadhi Kendras

New Delhi : The Union government has identified 2,000 primary agricultural credit societies (PACS) to serve as Pradhan Mantri Bhartiya Jan Aushadhi Kendras, which are low-cost pharmacies selling unbranded medicines, which officials said would bolster last-mile health care delivery.

“One thousand centres will start functioning by August and the next 1,000 by December this year,” an official said, declining to be named. The move follows a plan to diversify these farm-service points and an agreement overseen by home minister Amit Shah and health minister Mansukh Mandaviya.

The cooperation ministry, also headed by Shah, is currently ramping up a drive to digitize PACS, which act as last-mile financial institutions for millions of farmers, which will enable them to diversify their business activities.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the chemicals and fertilizers ministry headed by Mandaviya in November 2008 to make quality generic medicines available at affordable prices. These dispensing facilities sell generic drugs that are 50-90% cheaper than branded drugs.

The Centre has rolled out changes to revamp the cooperative sector. At the heart of the overhaul is the plan to digitise PACS. India has nearly 800,000 cooperatives with a total membership base of about 290 million individuals, including banks, sugar mills and businesses, such as fertilizer-maker IFFCO and milk brand Amul. Cooperatives are collectives jointly owned by participating members who share profits and losses.

To be eligible to dispense drugs under the scheme, a primary cooperative society needs at least 120 sq. ft space, either privately owned or rented. The application fee for a Jan Aushadhi Kendra is ₹5,000. Women entrepreneurs, differently abled citizens, and scheduled castes and tribes get priority under special categories. All fees are waived off for applications from the special category, the official said.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’